AWARDDEFINITIVE CONTRACTOther than small business
Definitive contract 75N92020C00014MESA BIOTECH INC
Overview
Award facts
- Net obligations
- $24.86M
- $24,860,014of $24.86M potential value
- Outlays (paid to date)
- $24.86M
- $24.86M paid of $24.86M obligated$24,860,014
- Period of performance
- Jul 30, 2020 to May 4, 2024
- Ended
- Modifications
- 10
- Latest action Jun 5, 2025
- Contract type
- Definitive contract
- PIID 75N92020C00014
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
EASY TO USE, LOW-COST MOLECULAR-BASED SARS-COV-2 TEST, HIGHLY SCALABLE RAPID ACCELERATION OF DIAGNOSTICS (RADX) PROGRAM: TECH PROJECT #2244 MESA BIOTECH, INC.
Dates and value
- Award date
- Signed on Jul 30, 2020
- Potential end of performance
- May 3, 2024
- Current value
- $24,860,014Base and exercised options
- Potential value (if all options are exercised)
- $24,860,014
Obligations by fiscal year of action
- FY2025: -$9,866,750 (de-obligation)
- FY2022: $19,383,000
- FY2021: $294,500
- FY2020: $15,049,264
Total across 4 fiscal years: $24,860,014
Net de-obligation in that fiscal year (obligations withdrawn).
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jun 5, 2025. View on USAspending
Recipient
NameMESA BIOTECH INC
Business sizeOther than small businessSize at award, per the contracting officer
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NHLBI
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NHLBI
- Funded from
- National institute of biomedical imaging and bioengineering (0898)Program activities075-0898Federal accounts (agency financial reports)
Place of performance
- Place of performance
- San Diego, California
Classification and competition
Classification
- Product or service (PSC)
- Q301REFERENCE LABORATORY TESTING (service)
Competition
- Extent competed
- Not competedC
- Reason not competed
- Urgency (FAR 6.302-2)URG
- Solicitation procedures
- Only one sourceSSS
- Set-aside
- No set-aside used
- Contract pricing
- Firm fixed priceJ
- Offers received
- 1
Contract details
- Subcontracting plan
- Plan not included - no subcontracting possibilitiesA
- Major program
- Rapid acceleration of diagnostics (RADX)
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- No
- Service Contract Act labor standards
- No
- Commercial procedures
- Commercial products/servicesA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- Yes - service where PBA is used.Y
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Jul 30, 2020Base obligation at award: $4,991,604
- Latest action
- Jun 5, 2025 — CloseoutModification P00010; obligation change -$9,866,750; administrative: no change in scope or value
- Latest substantive action
- Nov 30, 2023 — Change order definitizedModification P00009
- Actions by type
- Base award1
- Change order definitized3
- Other administrative action3
- Option exercised2
- Letter contract definitized1
- Closeout1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- -$9,866,750
- Latest action: change in base and all options
- -$9,866,750
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N920
- Transactions recorded under this award key
- 11
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N920
- Treasury accounts
- 075-2022/2022-0898-000
- 075-X-0898-000
- Object classes
- 25.2: Other services from non-Federal sources
- Disaster or emergency funding (DEFC)
- P: Emergency P.L. 116-139
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression
- COVID-19 supplemental obligations
- $15,168,514
- COVID-19 supplemental outlays
- $15,168,514